Taro Pharmaceutical Industries Ltd (NYSE:TARO)

118.86
Delayed Data
As of Jun 21
 0.00 / 0.00%
Today’s Change
93.01
Today|||52-Week Range
128.46
+13.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues161.3M169.9M155.5M175.2M
 
 
 
 
 
Cost of Goods Sold41.0M40.8M48.3M51.8M
 
 
 
 
 
Depreciation And Amortization3.8M4.0M4.2M4.5M
 
 
 
 
 
 
Operating ExpensesGross Income116.5M125.1M102.9M118.9M
 
 
 
 
 
General Expenses38.9M36.3M39.3M44.1M
 
 
 
 
 
Research And Development14.7M18.0M17.5M20.3M
 
 
 
 
 
Total Operating Expenses83.7M81.1M91.8M100.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income77.6M88.8M63.6M74.8M
 
 
 
 
 
Extraordinary Charge0.000.00-1.9M-24.0K
 
 
 
Other Expenses-17.5M-33.9M4.3M16.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income64.6M59.5M71.1M97.2M
 
 
 
 
 
Income Taxes-10.0M-6.9M-54.4M-10.7M
 
 
 
 
 
Minority Interest-58.0K-90.0K-1.4M-141.0K
 
 
 
 
 
Discontinued Operations-47.0K-145.0K-47.0K-96.0K
 
 
 
 
 
Net Income54.5M52.4M18.0M86.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.5M40.3M40.1M39.7M
 
 
 
 
 
Shares To Calculate EPS Diluted40.5M40.3M40.1M39.7M
 
 
 
 
 
 
Earnings Per ShareEPS$1.35$1.30$0.45$2.17
 
 
 
 
 
EPS Diluted$1.35$1.30$0.45$2.17